Tor Åge Myklebust

4.5k total citations
169 papers, 1.9k citations indexed

About

Tor Åge Myklebust is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tor Åge Myklebust has authored 169 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 56 papers in Surgery and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tor Åge Myklebust's work include Colorectal Cancer Screening and Detection (30 papers), Global Cancer Incidence and Screening (29 papers) and Spine and Intervertebral Disc Pathology (22 papers). Tor Åge Myklebust is often cited by papers focused on Colorectal Cancer Screening and Detection (30 papers), Global Cancer Incidence and Screening (29 papers) and Spine and Intervertebral Disc Pathology (22 papers). Tor Åge Myklebust collaborates with scholars based in Norway, Sweden and United States. Tor Åge Myklebust's co-authors include Bjørn Møller, Tom Børge Johannesen, Inger Kristin Larsen, Sophie D. Fosså, Trude Eid Robsahm, Bjørn Møller, Louise A. Brinton, Ritsa Storeng, Arne Wibe and Nan Birgitte Oldereid and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tor Åge Myklebust

154 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tor Åge Myklebust Norway	24	836	577	376	274	188	169	1.9k
Katherine Van Loon United States	21	956 1.1×	270 0.5×	267 0.7×	256 0.9×	209 1.1×	126	1.7k
David Wyld Australia	24	1.2k 1.4×	201 0.3×	423 1.1×	275 1.0×	342 1.8×	127	2.1k
Stacie Hudgens United States	22	535 0.6×	266 0.5×	335 0.9×	181 0.7×	91 0.5×	104	1.7k
Peter Grimison Australia	28	1.2k 1.5×	441 0.8×	405 1.1×	81 0.3×	325 1.7×	135	2.2k
Anke Bergmann Brazil	28	1.5k 1.8×	751 1.3×	289 0.8×	203 0.7×	461 2.5×	221	2.8k
Giovanni Rosti Italy	29	804 1.0×	878 1.5×	555 1.5×	124 0.5×	267 1.4×	127	2.7k
Rachel Waters United Kingdom	19	1.1k 1.3×	882 1.5×	348 0.9×	137 0.5×	391 2.1×	30	2.7k
Mette Gislum Denmark	28	632 0.8×	390 0.7×	267 0.7×	351 1.3×	351 1.9×	40	2.1k
Ragnhild Sørum Falk Norway	23	615 0.7×	279 0.5×	279 0.7×	199 0.7×	230 1.2×	130	1.9k
Wendy R. Brewster United States	24	429 0.5×	363 0.6×	269 0.7×	288 1.1×	173 0.9×	77	1.9k

Countries citing papers authored by Tor Åge Myklebust

Since Specialization

Citations

This map shows the geographic impact of Tor Åge Myklebust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tor Åge Myklebust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tor Åge Myklebust more than expected).

Fields of papers citing papers by Tor Åge Myklebust

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tor Åge Myklebust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tor Åge Myklebust. The network helps show where Tor Åge Myklebust may publish in the future.

Co-authorship network of co-authors of Tor Åge Myklebust

This figure shows the co-authorship network connecting the top 25 collaborators of Tor Åge Myklebust. A scholar is included among the top collaborators of Tor Åge Myklebust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tor Åge Myklebust. Tor Åge Myklebust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fosså, Sophie D., Torgrim Tandstad, Marianne Brydøy, et al.. (2025). Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge. European Urology Open Science. 72. 10–16. 1 indexed citations

Myklebust, Tor Åge, Sophie D. Fosså, Erik Skaaheim Haug, et al.. (2025). A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controls. Quality of Life Research. 34(9). 2689–2700.

Dahl, Alv A., et al.. (2024). A controlled study of use and effectiveness of phosphodiesterase-5 inhibitors in long-term survivors after curative radiotherapy for prostate cancer (PCa). Radiotherapy and Oncology. 204. 110704–110704.

Banitalebi, Hasan, Tor Åge Myklebust, Clemens Weber, et al.. (2024). Change in Lumbar Lordosis After Decompressive Surgery in Lumbar Spinal Stenosis Patients and Associations With Patient-Related Outcomes Two Years After Surgery: Radiologic and Clinical Results From the NORDSTEN Spinal Stenosis Trial. Spine. 50(1). 40–45. 2 indexed citations

Myklebust, Tor Åge, Inger Kristin Larsen, Tormod Kyrre Guren, et al.. (2024). Early-onset colorectal cancer incidence in Norway: a national registry-based study (1993-2022) analyzing subsite and morphology trends. SHILAP Revista de lepidopterología. 7. 100065–100065. 2 indexed citations

Myklebust, Tor Åge, Mats Remberger, Geir E. Tjønnfjord, et al.. (2024). Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors. SHILAP Revista de lepidopterología. 5(1). 117–124. 3 indexed citations

Myklebust, Tor Åge, Clemens Weber, Helena Brisby, et al.. (2024). Do patients with lumbar spinal stenosis benefit from decompression of levels with adjacent moderate stenosis? A prospective cohort study from the NORDSTEN study. The Spine Journal. 24(6). 1015–1021. 2 indexed citations

Banitalebi, Hasan, Tor Åge Myklebust, Clemens Weber, et al.. (2024). The association between lumbar lordosis preoperatively and changes in PROMs for lumbar spinal stenosis patients 2 years after spinal surgery: radiological and clinical results from the NORDSTEN-spinal stenosis trial. European Spine Journal. 33(5). 1950–1956. 1 indexed citations

Drogset, Jon Olav, et al.. (2024). Biomechanical comparison shows increased stability of an arthroscopic subscapular sling procedure compared to an open Latarjet reconstruction for anterior shoulder instability in specimens with major glenoid bone defect. Journal of Experimental Orthopaedics. 11(3). e70015–e70015. 1 indexed citations

10.

Årøen, Asbjørn, et al.. (2024). Arthroscopic meniscal surgery in Norway from 2010 to 2020: A paradigmatic shift. Journal of Experimental Orthopaedics. 11(4). e70113–e70113. 1 indexed citations

11.

Svendsen, Karianne, Lise Solberg Nes, Elin Børøsund, et al.. (2023). Coping After Breast Cancer: Protocol for a Randomized Controlled Trial of Stress Management eHealth Interventions. JMIR Research Protocols. 12. e47195–e47195. 4 indexed citations

12.

Hebelka, Hanna, et al.. (2023). Cervical Foraminal Changes in Patients with Intermittent Arm Radiculopathy Studied with a New MRI-Compatible Compression Device. Journal of Clinical Medicine. 12(20). 6493–6493.

13.

Forster, Rachel, Tor Åge Myklebust, Grace M. Egeland, et al.. (2022). Treatment and 30-Day Mortality after Myocardial Infarction in Prostate Cancer Patients: A Population-Based Study from Norway. Cardiology. 148(1). 83–92. 1 indexed citations

14.

Andersson, Therése, Mark J. Rutherford, Bjørn Møller, Paul C. Lambert, & Tor Åge Myklebust. (2022). Reference-Adjusted Loss in Life Expectancy for Population-Based Cancer Patient Survival Comparisons—with an Application to Colon Cancer in Sweden. Cancer Epidemiology Biomarkers & Prevention. 31(9). 1720–1726. 6 indexed citations

15.

Osterman, Erik, Tobias Sjöblom, Hartwig Kørner, et al.. (2021). Accurate population-based model for individual prediction of colon cancer recurrence. Acta Oncologica. 60(10). 1241–1249. 8 indexed citations

16.

Kvåle, Rune, et al.. (2019). Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer‐specific mortality. A population‐based study of 13 198 patients. The Prostate. 79(16). 1852–1860. 9 indexed citations

17.

Fosså, Sophie D., Rune Kvåle, Bjørn Møller, et al.. (2018). Is time from diagnosis to radical prostatectomy associated with oncological outcomes?. World Journal of Urology. 37(8). 1571–1580. 14 indexed citations

18.

Skyrud, Katrine Damgaard, Tor Åge Myklebust, Freddie Bray, et al.. (2017). How Many Deaths from Colorectal Cancer Can Be Prevented by 2030? A Scenario-Based Quantification of Risk Factor Modification, Screening, and Treatment in Norway. Cancer Epidemiology Biomarkers & Prevention. 26(9). 1420–1426. 10 indexed citations

19.

Storeng, Ritsa, Tor Åge Myklebust, Nan Birgitte Oldereid, et al.. (2017). Cancer Risk in Women Treated with Fertility Drugs According to Parity Status—A Registry-based Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 26(6). 953–962. 46 indexed citations

20.

Axcrona, Karol, Rune Kvåle, Bjørn Møller, et al.. (2017). Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway. Urology. 110. 140–147. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact